je.st
news
Tag: collaboration
Citrix adds IM to Podio enterprise collaboration software
2013-05-03 00:02:41| InfoWorld: Top News
Citrix has added instant messaging to its Podio enterprise collaboration product so that employees can engage in one-to-one and group text chats while they work on tasks and projects. This summer, Citrix will extend Podio Chat with audio communications and video conferencing, expanding the real-time communications features of the product. [ Discover what's new in business applications with InfoWorld's Technology: Applications newsletter. ]
Tags: software
enterprise
collaboration
adds
SEL Conference Promotes Innovation Through Collaboration
2013-05-02 17:45:00| Transmission & Distribution World
Schweitzer Engineering Laboratories, Inc. has announced the second annual Modern Solutions Power Systems Conference, which will take place June 57, 2013, in Chicago, Illinois. read more
Tags: conference
collaboration
innovation
promotes
Afraxis, Inc. And Servier Announce A Collaboration On ESP Platform For Drug Discovery In Central Nervous System Disorders
2013-05-01 06:34:08| drugdiscoveryonline News Articles
Afraxis, Inc. ("Afraxis") and Institut de Recherches Servier ("Servier") announced a non-exclusive platform collaboration using Afraxis' Enhanced Spine Platform (ESP) Technology for the discovery of drugs to treat central nervous system (CNS) disorders
Tags: system
central
drug
platform
Muhlbauer, NovaCentrix enter collaboration
2013-04-30 17:55:00| Label and Narrow Web Breaking News
The companies will team up to offer new RFID antenna manufacturing technology.
Tags: enter
collaboration
enter collaboration
Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
2013-04-29 13:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. & NEW YORK WHITEHOUSE STATION, N.J. & NEW YORK--(BUSINESS WIRE)--Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada (Merck), and Pfizer Inc. (NYSE:PFE) today announced that they have entered into a worldwide (except Japan) collaboration agreement for the development and commercialization of Pfizers ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes. Language: English Contact HTML: Merck Media Relations:Steven Cragle: (908) 423-3461Kim Hamilton: (908) 423-6831orPfizer Media Relations:Joan Campion: (212) 733-2798orMerck Investor Relations:Carol Ferguson: (908) 423-4465Justin Holko: (908) 423-5088orPfizer Investor Relations:Chuck Triano: (212) 733-3901 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: PFE Exchange: NYSE read more
Tags: for
type
enter
agreement
Sites : [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] next »